TENM3 and neuroblastoma: For Teneurin-3, decreased levels predicted a worse survival in neuroblastoma patients (Molenaar et al., 2012), while expression was upregulated in breast tissue of nulliparous women, known to be at higher risk of developing breast cancer (Balogh et al., 2006).